Showing 679 results
Archival description![[C] ZOT - Fuel Cell Manufacturing](/uploads/r/null/d/5/5/d55b8676f3b8f35c0a6a59c3fe37f7bad91914e2694a2b093fa3b76dc70aebbf/9d9c5ce2-f101-439c-bee8-a426b4b127cf-_C__zot-co-uk-newsitem-php-2021-02-05-17_37_47_142.jpg)
[C] ZOT - Fuel Cell Manufacturing
Calculation of ecological thresholds determines policies for restoration in the Atlantic Forest of Brazil
Calculation of ecological thresholds determines policies for restoration in the Atlantic Forest of Brazil
![[Ci] EMA Orkambi approval documents Approval for use in patients 12 years and older.pdf](/uploads/r/null/c/5/8/c5899e08d80d55921956995ba6877c3eb46975d987de0c6d571fb9cde8bff91b/52f73e0d-7dc5-4b7b-9f47-a8f415418a42-_Ci__EMA_Orkambi_approval_documents_Approval_for_use_in_patients_12_years_and_older_142.jpg)
[Ci] EMA Orkambi approval documents Approval for use in patients 12 years and older.pdf
![[Ci] Reports from Imperial College considered at SAGE meetings Meeting 9, 20th February 2020.pdf](/uploads/r/null/d/3/0/d30aad296c6a971c33e9428961f7c18672dcfdd40a64440a62265909840f9261/598f5731-e6cc-47a2-9abd-684d59852931-_Ci__Reports_from_Imperial_College_considered_at_SAGE_meetings_Meeting_9__20th_February_2020_142.jpg)
[Ci] Reports from Imperial College considered at SAGE meetings Meeting 9, 20th February 2020.pdf
![[Cii] EMA Orkambi approval documents Approval for use in patients 6 years and older.pdf](/uploads/r/null/0/e/6/0e6ea321eb24fd572a1dab7b64b3bf165cea74705c8afa1478fd0e62a2a60231/75b65d32-fa41-4f2f-83c1-b48de27c6f8b-_Cii__EMA_Orkambi_approval_documents_Approval_for_use_in_patients_6_years_and_older_142.jpg)
[Cii] EMA Orkambi approval documents Approval for use in patients 6 years and older.pdf
![[Cii] Reports from Imperial College considered at SAGE meetings Meeting 10, 25 February 2020.pdf](/uploads/r/null/9/7/8/978bc96a99e35fe0fe65168e9eb3275586993fdf58025b68e3b11effd99ef4db/28a11fd6-eaa7-48e3-9945-c551d1202174-_Cii__Reports_from_Imperial_College_considered_at_SAGE_meetings_Meeting_10__25_February_2020_142.jpg)
[Cii] Reports from Imperial College considered at SAGE meetings Meeting 10, 25 February 2020.pdf
![[Ciii] Reports from Imperial College considered at SAGE meetings Meeting 12, 3rd March 202.pdf](/uploads/r/null/9/e/1/9e142bd64dbf08ef758cf225d590c65327406c3340c3b2c39fa1ef67b7dd44f3/89230f03-fba9-4c8f-a46e-3f57d0df5898-_Ciii__Reports_from_Imperial_College_considered_at_SAGE_meetings_Meeting_12__3rd_March_202_142.jpg)
[Ciii] Reports from Imperial College considered at SAGE meetings Meeting 12, 3rd March 202.pdf
![[Civ] Reports from Imperial College considered at SAGE meetings Meeting 13, 5th March 2020.pdf](/uploads/r/null/9/0/7/907c42af2864e3ae81282939e005702be9b6ee477bac0bdcbd3c0c4958a34a88/43f0fc8b-3a78-439d-a6ae-0d7e26b13dd3-_Civ__Reports_from_Imperial_College_considered_at_SAGE_meetings_Meeting_13__5th_March_2020_142.jpg)
[Civ] Reports from Imperial College considered at SAGE meetings Meeting 13, 5th March 2020.pdf
Climate Change Risk Assessment for the Government of Cyprus
Climate Change Risk Assessment for the Government of Cyprus
Commercial impact of fluorescence lifetime imaging (FLIM) technology
Commercial impact of fluorescence lifetime imaging (FLIM) technology
Commercial impact of Phyre: A resource for computational modelling of the 3D structure of proteins
Commercial impact of Phyre: A resource for computational modelling of the 3D structure of proteins
Commercial impact of the ONETEP materials modelling software
Commercial impact of the ONETEP materials modelling software
Commercial investment in PsiQuantum – a photonic quantum computing company
Commercial investment in PsiQuantum – a photonic quantum computing company
Commercialisation of metamaterials delivering disruptive products in the optical, medical, aerospace, military and communications industries
Commercialisation of metamaterials delivering disruptive products in the optical, medical, aerospace, military and communications industries
![[D] British Medical Ultrasound Society guidelines.pdf](/uploads/r/null/1/f/8/1f8c2c4e435190aace18c7b04e6cc60171764254e6964f328fe635d5c9d4d84a/142cb58d-8ac3-479d-813b-36f554d5cc4b-_D__British_Medical_Ultrasound_Society_guidelines_142.jpg)
[D] British Medical Ultrasound Society guidelines.pdf
![[D] BSGACPGBIPHE Post polypectomy and post colorectal cancer resection surveillance guidelines.pdf](/uploads/r/null/b/3/2/b32916169f7762a553a40633af5f8c4acd6f0fcd93ca9be871145ba39a392a68/7d535a01-622d-41ee-9cb5-2955b1be67db-_D__BSGACPGBIPHE_Post_polypectomy_and_post_colorectal_cancer_resection_surveillance_guidelines_142.jpg)
[D] BSGACPGBIPHE Post polypectomy and post colorectal cancer resection surveillance guidelines.pdf
![[D] Carrick Therapeutics Press announces first patient on CT7001 30th Nov 2017.pdf](/uploads/r/null/f/f/d/ffda5c3a4f4c68f44f65e474e112a266e2803f92ccf4b171cdfa225656c0046e/5e03e674-eb70-4c02-b12a-fa2b260f1f54-_D__Carrick_Therapeutics_Press_announces_first_patient_on_CT7001_30th_Nov_2017_142.jpg)
[D] Carrick Therapeutics Press announces first patient on CT7001 30th Nov 2017.pdf
![[D] Combined evidence of impact within France](/uploads/r/null/e/a/0/ea05b73e27472767e01a297efb580248dd37e25ff8c300cefefb8e993ee597d3/6bd74d97-ad37-40a6-aefb-45b1872f8480-_D__Impact_in_France_142.jpg)
[D] Combined evidence of impact within France
![[D] CustoMem changes name to Puraffinity, secures new funds](/uploads/r/null/e/9/5/e95a51873b7a3dc582de3f84a707b10e498acc41ae289c7b10ed1e5183f63ff0/b560cd31-2e06-4483-a0da-77493d4ba728-_D__screencapture-wwtonline-co-uk-news-customem-changes-name-to-puraffinity-secures-new-funds-2021-03-02-09_22_58_142.jpg)
[D] CustoMem changes name to Puraffinity, secures new funds
![[D] DEDICATED TO CHANGE Aerodynamic efficiency as key enabler for flying greener](/uploads/r/null/2/f/b/2fba9d4ffb536eb2dd15b14e000d77606d87bb2a79db9e181d0951fcb5612a41/14f61f87-1e5d-4fa7-83a8-f2106d8c2c91-_D__screencapture-hlfc-win-eu-environmental-responsibility-2021-03-09-09_52_24_142.jpg)
[D] DEDICATED TO CHANGE Aerodynamic efficiency as key enabler for flying greener